登录新浪财经APP 搜索【信披】查看更多考评等级 上海久诚律师事务所股票索赔律师许峰提示，红相股份（维权）（300427）虚假陈述引发的投资者索赔 案已经进入倒计时，目前诉讼时效仅剩下最后三个月左右，"过期作废"。（许峰律师专栏） 许峰律师代理的红相股份投资者索赔案已多次向法院提交立案，目前正在等待法院的安排。律师团队还 在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。2026年1月23日，律师再代理 投资者向法院提交一次立案。 需要注意的是，红相股份实控人此前曾作出承担投资者赔偿责任的承诺。律师提示，虽然有承诺，投资 者实际获赔需要以起诉为基础。 2024年4月3日晚，红相股份公告收到证监会厦门监管局《行政处罚决定书》，经查明，红相股份及相关 人员存在以下违法事实： （二）2020年公开发行可转换公司债券构成欺诈发行。 （三）2020年申请发行股份及支付现金购买资产并募集配套资金公告发行文件存在重大虚假记载。 专门从事股票索赔法律事务的上海久诚律师事务所主任许峰律师认为，在2018年3月30日到2023年4月29 日之间买入红相股份股票，并且在2023年4月29日后卖出或持有股票的投资者，还 ...

Core Viewpoint - The article discusses the ongoing legal issues faced by Peng Bo Shi (stock code: 600804) due to false statements and undisclosed transactions, leading to investor claims and regulatory penalties [1][4]. Group 1: Legal Proceedings - A batch of mediation documents has been received for investor claims against Peng Bo Shi, with further cases being filed in court [1][3]. - The law firm representing the investors has applied for enforcement of court decisions, as Peng Bo Shi has not complied with previous mediation agreements [1][3]. - Investors have won a certain percentage of their claims in a recent court ruling, and the legal team continues to accept new claims from other investors [3] Group 2: Regulatory Findings - On August 16, 2024, Peng Bo Shi received an administrative penalty from the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and significant contracts [4]. - The company’s annual reports from 2012 to 2022 contained false records, including a profit inflation of 42,456,137.95 yuan in 2012, which accounted for 17.43% of that year's total profit [4]. - From 2012 to 2015, Peng Bo Shi inflated its assets in annual reports, with a reported asset and profit inflation of 162 million yuan in 2016, representing 17.48% of that year's total profit [4]. - The company reported a reduction in net assets of 196 million yuan annually from 2020 to 2022, which constituted 21.77%, 14.27%, and 18.51% of the net assets at the end of each respective year [4]. Group 3: Investor Claims - Investors who purchased shares between April 12, 2013, and July 18, 2023, and sold or held them after July 18, 2023, are eligible to initiate claims [2][4].

Core Viewpoint - The article discusses the ongoing legal proceedings related to Zhuolang Technology, highlighting the company's false statements that led to investor claims and subsequent compensation rulings [2][3][4]. Group 1: Legal Proceedings and Compensation - Zhuolang Technology's investor compensation case has entered a batch mediation phase, with significant progress reported as investors have begun receiving compensation following court rulings in their favor [3][4]. - The first investor represented by attorney Xu Feng has successfully won the case and received the awarded compensation, with the legal team continuing to accept claims from other investors [3][4]. Group 2: Financial Misconduct - Zhuolang Technology's subsidiary, Tianjin Zhuolang Technology Development Co., Ltd., was found to have fabricated sales of servers, software, and system integration services, resulting in inflated revenues and profits from 2019 to 2023 [2][4]. - The inflated revenues reported were 249.15 million yuan, 489.13 million yuan, 338.61 million yuan, 656.13 million yuan, and 82.25 million yuan for the respective years, constituting 21.05%, 45.19%, 41.60%, 72.46%, and 13.22% of the disclosed revenue [2][4]. - The inflated profit totals were 249.15 million yuan, 309.90 million yuan, 338.61 million yuan, 357.13 million yuan, and 82.25 million yuan, representing 33.81%, 7.68%, 41.26%, 86.08%, and 50.27% of the disclosed profit totals [2][4]. Group 3: Investor Rights and Claims - Investors who purchased Zhuolang Technology stock between September 24, 2019, and March 15, 2024, and sold or held the stock after March 15, 2024, are still eligible to initiate claims [3][5]. - The legal services provided by Xu Feng's law firm do not incur any costs for investors who do not receive compensation [5].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 上海久诚律师事务所股票索赔律师许峰提示，红相股份（维权）（300427）虚假陈述引发的投资者索赔 案已经进入倒计时，目前诉讼时效仅剩下最后三个月左右，"过期作废"。（许峰律师专栏） 许峰律师代理的红相股份投资者索赔案已多次向法院提交立案，目前正在等待法院的安排。律师团队还 在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。2026年1月23日，律师再代理 投资者向法院提交一次立案。 需要注意的是，红相股份实控人此前曾作出承担投资者赔偿责任的承诺。律师提示，虽然有承诺，投资 者实际获赔需要以起诉为基础。 2024年4月3日晚，红相股份公告收到证监会厦门监管局《行政处罚决定书》，经查明，红相股份及相关 人员存在以下违法事实： 一、信息披露违法违规 红相股份2017年-2022年年度报告存在虚假记载。红相股份及其子公司厦门红相信息科技有限公司等 ...

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 投资者索赔需提供证券开户信息查询单、股票对账单（2017年1月1日至2021年12月底）、联系方式等。 【本文由浙江裕丰律师事务所厉健律师供稿，不代表新浪财经的立场。厉健律师，系中国法学会证券法 学研究会理事、中国证券业协会证券纠纷调解员，2009年荣获"浙江省优秀青年律师"称号。2003年至 今，厉健律师代理投资者告赢五粮液、大智慧等130余家上市公司并获赔，成效显著。其中，祥源文 化、赵薇案入选2019年度人民法院十大商事案例，杭萧钢构（维权）案入选2012年度"全国法院十大调 解案例"，辉丰股份案系江苏省首例证券纠纷普通代表人案。厉健律师接受中央电视台、新华社、证券 时报、证券日报、中国证券报、人民法院报、第一财经等100余家新闻媒体采访一千余篇（次）。执业 证号：13301200210145176）】 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 近日，曾代理投资者告赢130余家上市公司并获赔的浙江裕丰律师事务所厉健律师表示，根据证监会对 ...

Core Viewpoint - The articles discuss ongoing investor compensation cases against companies Xilong Science and Puli Pharmaceutical due to false financial disclosures, highlighting the legal actions taken by investors and the financial discrepancies identified by regulatory authorities [1][2][4][5]. Group 1: Xilong Science - Xilong Science has faced legal actions due to false statements leading to investor compensation claims, with a recent case submitted to the Shantou Intermediate People's Court [1][4]. - The company was found to have inflated its financial figures significantly, with 2020 showing inflated revenue of approximately 597.65 million yuan, costs of about 595.99 million yuan, and profits of around 1.66 million yuan, representing 9.57%, 10.34%, and 2.04% of total revenue, costs, and profits respectively [1][4]. - For 2021, the inflated revenue was approximately 1.46 billion yuan, costs around 1.44 billion yuan, and profits about 13.48 million yuan, accounting for 21.32%, 22.98%, and 5.93% of total revenue, costs, and profits respectively [1][4]. Group 2: Puli Pharmaceutical - Puli Pharmaceutical is also facing investor compensation claims, with a recent case submitted to the Haikou Intermediate People's Court, where investors have won a preliminary judgment [2][5]. - The company was found to have overstated its revenue by approximately 514.60 million yuan in 2021, which constituted 34.11% of the reported revenue, and inflated profits by about 308.02 million yuan, making up 65.88% of the total profit [2][5]. - In 2022, the company overstated its revenue by approximately 515.90 million yuan, representing 28.56% of the reported revenue, and inflated profits by about 387.42 million yuan, which was 88.27% of the total profit [2][5]. Group 3: Legal Context - Investors who purchased shares of Puli Pharmaceutical between April 26, 2022, and April 17, 2024, or shares of Xilong Science between April 29, 2021, and April 29, 2023, are eligible to initiate compensation claims [3][6]. - The legal actions are being led by attorney Xu Feng from Shanghai Jucheng Law Firm, who has extensive experience in securities fraud cases [3][6].

Group 1 - The core issue involves investor claims against Guangyuyuan (600771) for false statements, with ongoing legal proceedings initiated by attorney Xu Feng [1] - The company was found to have misrepresented its "buyout sales" model in annual reports from 2016 to 2021, leading to premature revenue recognition and incorrect handling of sales expenses [1] - The administrative penalty from the China Securities Regulatory Commission (CSRC) was issued on April 11, 2024, confirming the violations [1] Group 2 - Investors who purchased Guangyuyuan stock between March 21, 2017, and December 29, 2023, are eligible to file claims [2] - Attorney Xu Feng is also handling claims for Tianwo Technology (002564), which has seen successful settlements for some investors [2] - Tianwo Technology was found to have false records in its periodic reports and failed to disclose related party transactions and the use of raised funds [3][4]

Core Viewpoint - Xiamen Road and Bridge Information Co., Ltd. (referred to as "Road and Bridge Information") has been penalized by the China Securities Regulatory Commission (CSRC) for financial misconduct, including inflating revenue and profits through false contracts and fictitious sales [2][6]. Group 1: Financial Misconduct Details - Road and Bridge Information inflated its operating revenue by CNY 15,835,974.32 in 2023 and CNY 25,764,001.49 in 2024, accounting for 6.66% and 10.71% of the disclosed annual revenue for those years, respectively [2][6]. - The company also inflated its profits by CNY 15,307,059.32 in 2023 and CNY 22,459,275.84 in 2024, representing 73.57% and 103.50% of the disclosed total profit for those years, respectively [2][6]. Group 2: Regulatory Actions and Announcements - On September 29, 2025, Road and Bridge Information issued a correction announcement regarding prior accounting errors that affected the financial statements [2][6]. - The CSRC's Xiamen Regulatory Bureau decided to issue warnings and impose fines on Road and Bridge Information and its responsible personnel due to the violations [2][6]. Group 3: Investor Compensation and Legal Actions - Investors who suffered losses due to the company's misconduct can seek civil compensation, which includes investment differences, commissions, and stamp duties [3][7]. - A lawyer from Shanghai Hanlian Law Firm is collecting claims from investors who purchased Road and Bridge Information's securities between April 23, 2024, and September 29, 2025, and sold or continued to hold them after September 30, 2025 [3][7]. - The conditions for compensation claims may be adjusted based on the CSRC's administrative penalties and the final court rulings [8].

Core Viewpoint - The article discusses the legal developments regarding Zhongzhuang Construction (002822) and the ongoing investor compensation claims due to false statements made by the company [1][3]. Group 1: Legal Proceedings - On January 15, 2026, a new investor compensation case for Zhongzhuang Construction was filed in the Shenzhen Intermediate People's Court, indicating significant progress in the ongoing legal battle [1][3]. - The Shenzhen Intermediate Court has ruled in favor of investors in a first-instance judgment related to the compensation claims against Zhongzhuang Construction [1][3]. Group 2: Financial Misconduct - Zhongzhuang Construction and its subsidiary, Shenzhen Zhongzhuang Municipal Garden Engineering Co., Ltd., were found to have misclassified internal contracting projects as self-operated projects, leading to understated costs and inflated profits [2][4]. - The inflated profit amounts from 2017 to 2021 were reported as follows: 18.33 million (9.06%), 12.92 million (5.26%), 43.99 million (14.74%), 13.02 million (3.91%), and 16.10 million (8.88%), which resulted in false disclosures in the annual reports for those years [2][4]. Group 3: Investor Compensation Eligibility - Investors who purchased Zhongzhuang Construction shares between April 16, 2018, and December 16, 2023, and sold or continued to hold the shares after December 16, 2023, are still eligible to initiate compensation claims [3][5]. - The law firm representing the investors has a history of successfully handling compensation cases, with nearly 200 cases won or settled favorably for investors [3][5].

Core Viewpoint - Weichuang Co., Ltd. (002308) is facing legal claims from investors due to false statements and violations of information disclosure regulations, as highlighted by the administrative penalty issued by the Guangdong Regulatory Bureau of the CSRC [1][3][4]. Summary by Relevant Sections Legal Proceedings - The law firm Shanghai Jucheng, represented by lawyer Xu Feng, has submitted multiple claims to the Guangzhou Intermediate People's Court regarding investor compensation related to Weichuang Co., Ltd. [1][2] - The law firm is actively accepting additional claims from other investors affected by the company's alleged misconduct [1][2]. Regulatory Findings - On February 21, 2025, Weichuang Co., Ltd. received an administrative penalty from the CSRC, which identified several violations: - The actual controller change was not disclosed by Lu Keping, leading to false records in the company's 2023 semi-annual report [3][4]. - Liu Jun failed to report the acquisition agreement in a timely manner, and Lu Keping did not inform the company of significant changes in control, resulting in further disclosure failures [4]. - The company did not timely disclose non-operating fund occupation by related parties [4]. - The third-quarter report for 2023 also contained false records regarding non-operating fund transactions with related parties [4]. Investor Compensation Eligibility - Investors who purchased Weichuang Co., Ltd. shares between June 21, 2023, and December 23, 2023, and sold or held the shares after December 23, 2023, are eligible to initiate compensation claims [4].